Epsilon Healthcare (ASX:EPN) - Cours de l'action, nouvelles et analyse

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

EPN Aperçu des actions

Epsilon Healthcare Limited operates as a healthcare and pharmaceuticals company primarily in Australia and Canada.

EPN analyse fondamentale
Score flocon de neige
Évaluation	2/6
Croissance future	0/6
Performances passées	0/6
Santé financière	2/6
Dividendes	0/6

Récompenses

Analyse des risques

Les revenus ont diminué de 4.2% par an au cours des 5 dernières années

N'a pas de capitalisation boursière significative ( A$7M )

Les actions sont très illiquides

A moins d'un an de piste de trésorerie

+ 1 plus de risques

Epsilon Healthcare Limited Concurrents

Island Pharmaceuticals

ASX:ILA

AU$8.2m

Cann Global

ASX:CGB

AU$5.4m

Avecho Biotechnology

ASX:AVE

AU$9.5m

Nyrada

ASX:NYR

AU$10.0m

Historique des prix et performances

Résumé des plus hauts, des changements et des baisses de prix pour Epsilon Healthcare
Historique des cours de bourse
Prix actuel de l'action	AU$0.024
Plus haut sur 52 semaines	AU$0.034
Plus bas sur 52 semaines	AU$0.016
Bêta	0.92
1Variation sur 1 mois	0%
Variation sur 3 mois	0%
Variation sur 1 an	20.00%
3Variation sur 3 ans	-89.57%
Variation sur 5 ans	-95.60%
Évolution depuis l'introduction en bourse	-94.07%

Nouvelles et mises à jour récentes

Recent updates

Rendement pour les actionnaires

	EPN	AU Pharmaceuticals	AU Marché
7D	0%	0.9%	2.2%
1Y	20.0%	52.4%	11.2%

Rendement vs Industrie: EPN a sous-performé le secteur Australian Pharmaceuticals qui a rapporté 52.4 % au cours de l'année écoulée.

Rendement vs marché: EPN a dépassé le marché Australian qui a rapporté 11.2 % au cours de l'année écoulée.

Volatilité des prix

Is EPN's price volatile compared to industry and market?
EPN volatility
EPN Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	10.1%
Market Average Movement	8.2%
10% most volatile stocks in AU Market	16.9%
10% least volatile stocks in AU Market	3.4%

Cours de l'action stable: EPN n'a pas connu de volatilité de prix significative au cours des 3 derniers mois.

Volatilité au fil du temps: Données insuffisantes pour déterminer l'évolution de la volatilité de EPN au cours de l'année écoulée.

À propos de l'entreprise

Fondée	Salariés	PDG	Site web
2016	n/a	Daniel Sanghera	epsilonhealthcare.com.au

Epsilon Healthcare Limited Résumé des fondamentaux

Comment les bénéfices et les revenus de Epsilon Healthcare se comparent-ils à sa capitalisation boursière ?
EPN statistiques fondamentales
Capitalisation boursière	AU$7.21m
Bénéfices(TTM)	-AU$5.93m
Recettes(TTM)	AU$7.21m

1.0x

Ratio P/S

-1.2x

Ratio P/E

Le site EPN est-il surévalué ?

Voir Juste valeur et analyse de l'évaluation

Bénéfices et recettes

Principales statistiques de rentabilité tirées du dernier rapport sur les bénéfices (TTM)
EPN compte de résultat (TTM)
Recettes	AU$7.21m
Coût des recettes	AU$5.09m
Marge brute	AU$2.12m
Autres dépenses	AU$8.05m
Les revenus	-AU$5.93m

Derniers bénéfices déclarés

Jun 30, 2023

Prochaine date de publication des résultats

s/o

Résultat par action (EPS)	-0.02
Marge brute	29.46%
Marge bénéficiaire nette	-82.17%
Ratio dettes/capitaux propres	27.1%

Quelles ont été les performances à long terme de EPN?

Voir les performances historiques et les comparaisons

EPN Aperçu des actions

Récompenses

Analyse des risques

Epsilon Healthcare Limited Concurrents

ASX:ILA

AU$8.2m

ASX:CGB

AU$5.4m

ASX:AVE

AU$9.5m

ASX:NYR

AU$10.0m

Historique des prix et performances

Nouvelles et mises à jour récentes

Epsilon Healthcare Appoints Richard Legge as Company Secretary

Epsilon Healthcare Limited Announces Termination of Xiao (Josh) Cui as Company Secretary

Epsilon Healthcare Receive Notice from Watercrest Asset Management Pty Ltd

Epsilon Healthcare Receive Notice from Watercrest Asset Management Pty Ltd

Epsilon Healthcare Limited Announces Board Appointments

Epsilon Healthcare Limited Announces Terminates Peter Giannopoulos as Chief Executive Officer

Recent updates

Epsilon Healthcare Appoints Richard Legge as Company Secretary

Epsilon Healthcare Limited Announces Termination of Xiao (Josh) Cui as Company Secretary

Epsilon Healthcare Receive Notice from Watercrest Asset Management Pty Ltd

Epsilon Healthcare Receive Notice from Watercrest Asset Management Pty Ltd

Epsilon Healthcare Limited Announces Board Appointments

Epsilon Healthcare Limited Announces Terminates Peter Giannopoulos as Chief Executive Officer

Does Epsilon Healthcare (ASX:EPN) Have A Healthy Balance Sheet?

Non-Executive Deputy Chairman recently bought AU$67k worth of stock

First half 2023 earnings released: AU$0.002 loss per share (vs AU$0.035 loss in 1H 2022)

Non-Executive Deputy Chairman recently bought AU$55k worth of stock

Is Epsilon Healthcare (ASX:EPN) Using Too Much Debt?

New minor risk - Share price stability

Epsilon Healthcare Appoints Peter Giannopoulos as Chief Executive Officer, Effective 23 May, 2023

Full year 2022 earnings released: AU$0.066 loss per share (vs AU$0.048 loss in FY 2021)

Epsilon Healthcare Limited Announces Executive Changes

Epsilon Healthcare Limited Appoints Mark Audet as Chief Financial Officer

No independent directors

Epsilon Healthcare Limited Announces Resignation of Simon Rowe as Director

Epsilon Healthcare Limited Announces Board Changes

Epsilon Healthcare Limited Announces Resignation of Nicholas Marshall as Chief Financial Officer

Epsilon Healthcare Limited Announces Executive Changes

First half 2022 earnings released: AU$0.035 loss per share (vs AU$0.022 loss in 1H 2021)

Epsilon Healthcare Limited Announces Resignation of Dr. Rob Jenny as A Director

Epsilon Healthcare Limited Announces Resignation of Jarrod White as Chief Executive Officer

Epsilon Healthcare Limited Appoints Patrick Baiyu Xu as Director

Epsilon Healthcare Limited, Annual General Meeting, May 31, 2022

Epsilon Healthcare Limited announced that it expects to receive AUD 2.1 million in funding

No independent directors

Full year 2021 earnings released: AU$0.046 loss per share (vs AU$0.066 loss in FY 2020)

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Epsilon Healthcare Limited announced that it expects to receive AUD 2.898 million in funding from CPS Capital

First half 2021 earnings released: AU$0.022 loss per share (vs AU$0.039 loss in 1H 2020)

We Think Epsilon Healthcare (ASX:EPN) Has A Fair Chunk Of Debt

Epsilon Healthcare Limited (ASX:EPN) entered into binding heads of agreement to acquire AlternaMed Pty Ltd. from Cannvalate PTY LTD for AUD 4.3 million.

First half 2021 earnings released: AU$0.022 loss per share (vs AU$0.039 loss in 1H 2020)

Joint Company Secretary Philip Leighfield has left the company

Is Epsilon Healthcare (ASX:EPN) Weighed On By Its Debt Load?

Tetra Health Partners with Astrid Healthcare to Operates the Astrid Dispensary in South Yarra

Non Executive Director has left the company

Epsilon Healthcare Limited Announces Resignation of Gary Radcliff as Non-Executive Director

Is Epsilon Healthcare (ASX:EPN) Using Too Much Debt?

Full year 2020 earnings released: AU$0.069 loss per share (vs AU$0.088 loss in FY 2019)

THC Global Group Limited announced that it expects to receive AUD 2.75 million in funding

New 90-day high: AU$0.29

THC Global Group Limited Announces CEO Changes

First half earnings released

New 90-day low - AU$0.24

New 90-day low - AU$0.26

THC Global Group Limited (ASX:THC) completed the acqusition of Tetra Pty Ltd from Meta Growth Corp. (TSXV:META) and others.

New 90-day low - AU$0.27

THC Global Group Limited has completed a Follow-on Equity Offering in the amount of AUD 1.535 million.

Rendement pour les actionnaires

Volatilité des prix

À propos de l'entreprise

Epsilon Healthcare Limited Résumé des fondamentaux

1.0x

-1.2x

Bénéfices et recettes